[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fxB4WyR4jAYGaLz4epHWp0-jWfCs0GRkLtY_AqM0dxR0":8,"$f4LSFhvo5gVjwig72LCAAPyKl_USUIibOx1tgdYZJaTs":55,"$fJ2kWl2VLLgyR7p8P99C1EFx3L82Q5ZAP3dY_ddYKiBA":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},75851,868619,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//9kt9P8itRMTEhPWBKSqeKk35MiGS2Hii.png","李玲","新泰市人民医院","肿瘤科","主治医师",64,0,"三期乳腺癌靶向治疗：科学认识与实用指南","","https://ystcdn.venuertc.com/venue/AI/7d195d17-7502-4ba7-a4fc-57b419682944.jpg","\u003Cdiv id=\"material_title\" class=\"bc-guide-title\">\n    三期乳腺癌靶向治疗：科学认识与实用指南\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n    \u003Cdiv class=\"bc-section-header\" style=\"background:linear-gradient(90deg,#e6f3fb 0%,#f9fafb 100%);\">\n        \u003Ch2 class=\"bc-section-title\">01 认知基础：什么是靶向药物？🎯\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bc-section-content\">\n        \u003Cp>\n            说起来，靶向药物是一类专门针对肿瘤细胞的药品。它们区别于传统化疗，主要通过锁定某些特定分子（比如 Her-2 受体）来阻断肿瘤生长。市面上的靶向药通常有注射液和口服片剂两类，剂型不同，使用方式也会有差异。\n        \u003C/p>\n        \u003Cp>\n            本文将聚焦于药品的成分、服用方法、剂型差异、相互作用、不良反应、储存要求和特殊情况处理这七个核心问题，让你用药时心里有底，避免常见风险。\n        \u003C/p>\n    \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n    \u003Cdiv class=\"bc-section-header\" style=\"background:linear-gradient(90deg,#f7f6fb 0%,#ebfafa 100%);\">\n        \u003Ch2 class=\"bc-section-title\">02 药品成分与剂型：弄清楚用的是什么💊\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bc-section-content\">\n        \u003Cp>\n            三期乳腺癌常用的靶向药物主要是曲妥珠单抗（Trastuzumab）、帕妥珠单抗（Pertuzumab）等两大类。主要成分均为人源化抗 Her-2 单克隆抗体，它们通过识别并结合肿瘤细胞表面的 Her-2 蛋白，从而阻断信号通路。\n        \u003C/p>\n        \u003Cp>\n            \u003Cstrong>剂型区别：\u003C/strong>\n            \u003Cbr>\n            曲妥珠单抗有注射液（静脉滴注或皮下注射），帕妥珠单抗为静脉注射。使用时需严格按照剂型说明，注射液不可用于口服。口服靶向药如拉帕替尼（Lapatinib）为片剂，必须整片吞服，不可掰开、嚼碎。\n        \u003C/p>\n        \u003Cp>\n            正确做法：用药前确认药品名称、成分及剂型，遇到不确定时及时咨询药师或医生。\n        \u003C/p>\n    \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n    \u003Cdiv class=\"bc-section-header\" style=\"background:linear-gradient(90deg,#faefe6 0%,#f2f8fa 100%);\">\n        \u003Ch2 class=\"bc-section-title\">03 药理机制：靶向药物的核心作用🧬\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bc-section-content\">\n        \u003Cp>\n            这些单抗类靶向药物的药理机制非常直接——通过结合 Her-2 受体，阻断肿瘤细胞活跃的信号传递链，减缓甚至抑制细胞分裂与增殖。部分药物还能引发免疫系统介导的细胞杀伤（ADCC）。\n        \u003C/p>\n        \u003Cp>\n            \u003Cstrong>数据表明：\u003C/strong>曲妥珠单抗联合化疗用于 Her-2 阳性患者时，药物有效率通常可达70%以上（Bang et al., 2013）。\n        \u003C/p>\n        \u003Cp>\n            \u003Cem>\n                本段只讲机制，不涉及具体使用方式。后续部分会细致说明具体的用药方法。\n            \u003C/em>\n        \u003C/p>\n    \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n    \u003Cdiv class=\"bc-section-header\" style=\"background:linear-gradient(90deg,#effaf2 0%,#eaf3fb 100%);\">\n        \u003Ch2 class=\"bc-section-title\">04 用法用量：怎么使用才最安全？⏰\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bc-section-content\">\n        \u003Cp>\n            \u003Cstrong>注射类：\u003C/strong>静脉滴注通常间隔为每21天一次，首次负荷剂量高于维持剂量。部分药物可做皮下注射，宜在专业人员操作下完成。\n        \u003C/p>\n        \u003Cp>\n            \u003Cstrong>口服类：\u003C/strong>拉帕替尼片应每日按规定剂量整个吞服，并在餐前1小时或餐后2小时服用，避免与食物同服影响吸收。\n        \u003C/p>\n        \u003Cul>\n            \u003Cli>服用方法必须严格按照药品说明书，不得自行调整剂量或更改服用频率。\u003C/li>\n            \u003Cli>漏服时，不可补服双倍剂量，应直接进行下一次正常服药。\u003C/li>\n            \u003Cli>过量服用后要密切观察不良反应，如有异常应及时就医。\u003C/li>\n        \u003C/ul>\n        \u003Cp>\n            \u003Cstrong>实例：\u003C/strong>\n            一位50余岁女性连续规范接受曲妥珠单抗注射治疗10周期，未出现不良反应，提示规律用药有助于降低风险并提高药物疗效。\n        \u003C/p>\n    \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n    \u003Cdiv class=\"bc-section-header\" style=\"background:linear-gradient(90deg,#f9f3ea 0%,#f2f7fa 100%);\">\n        \u003Ch2 class=\"bc-section-title\">05 药物相互作用：同时用药要注意什么？💡\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bc-section-content\">\n        \u003Cp>\n            靶向药物与部分化疗药物、心脏用药、降糖药、抗凝剂等可能存在相互作用，增加毒性或降低疗效。比如拉帕替尼与 CYP3A4 抑制剂（如酮康唑）合用时，血药浓度可大幅升高，需密切监测。\n        \u003C/p>\n        \u003Cul>\n            \u003Cli>曲妥珠单抗和帕妥珠单抗与化疗药物常联合使用，但需由专业医生评估相互作用和风险。\u003C/li>\n            \u003Cli>拉帕替尼在服用期间，避免同时使用含有强效酶抑制或诱导作用的药品（如利福平、伊曲康唑）。\u003C/li>\n            \u003Cli>如有血糖异常或静脉血栓的背景，靶向药物与抗凝/降糖药物的联合须谨慎，具体方案要由医生制定。\u003C/li>\n        \u003C/ul>\n        \u003Cp>\n            正确做法：开始新药前主动告知医生您正在使用的所有药品（包括保健品、OTC），逐一排查药物相互作用风险。\n        \u003C/p>\n    \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n    \u003Cdiv class=\"bc-section-header\" style=\"background:linear-gradient(90deg,#e6fbe6 0%,#f7f5fb 100%);\">\n        \u003Ch2 class=\"bc-section-title\">06 不良反应识别与处理🚩\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bc-section-content\">\n        \u003Cp>\n            曲妥珠单抗常见不良反应包括注射部位反应、发热、轻度过敏，少数情况下可致心脏功能受损（发生率约2-7%\u003Csup>[1]\u003C/sup>）。拉帕替尼口服易出现腹泻、皮疹，严重者需暂停用药。\n        \u003C/p>\n        \u003Cul>\n            \u003Cli>发现皮疹、腹泻、明显不适，应及时停药并联系医生。\u003C/li>\n            \u003Cli>注射后数小时如有呼吸困难、心悸、面色改变，要立即到医院处理。\u003C/li>\n        \u003C/ul>\n        \u003Cp>\n            一位患者连续规范用药后未出现不良反应，说明按照指南操作可大幅降低副作用风险。\n        \u003C/p>\n        \u003Cp>\n            \u003Cstrong>出现严重反应的处理：\u003C/strong>如呼吸困难、剧烈胸闷、持续高热——立即停用药物并就医。\n        \u003C/p>\n    \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n    \u003Cdiv class=\"bc-section-header\" style=\"background:linear-gradient(90deg,#f6faf6 0%,#eaf1fa 100%);\">\n        \u003Ch2 class=\"bc-section-title\">07 特殊人群用药调整👩‍⚕️\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bc-section-content\">\n        \u003Cp>\n            \u003Cstrong>老年患者：\u003C/strong>需要密切关注心脏功能，靶向药剂量通常不需要调整，但每次注射前要监测心脏超声。\n        \u003C/p>\n        \u003Cp>\n            \u003Cstrong>肝肾功能不全者：\u003C/strong>拉帕替尼等口服药需根据肝肾功能调整剂量或间隔。曲妥珠单抗和帕妥珠单抗无明显剂量调整要求，但特殊情况应询问药师。\n        \u003C/p>\n        \u003Cp>\n            \u003Cstrong>孕妇与哺乳期：\u003C/strong>靶向药物通常孕期禁用，哺乳期谨慎，必须在医生指导下决定是否用药或调整方案。\n        \u003C/p>\n    \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n    \u003Cdiv class=\"bc-section-header\" style=\"background:linear-gradient(90deg,#f3faeb 0%,#eaebfa 100%);\">\n        \u003Ch2 class=\"bc-section-title\">08 储存方法与有效期：用药细节别忽视📦\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bc-section-content\">\n        \u003Cp>\n            靶向药物大多数为注射液，储存要求较严格。曲妥珠单抗、帕妥珠单抗需冷藏（2-8°C），避免冻存和高温。拉帕替尼片应避免潮湿和阳光直射，常温下保存。\n        \u003C/p>\n        \u003Cul>\n            \u003Cli>开封后，如果药液出现颗粒、变色等异常，不可再用。\u003C/li>\n            \u003Cli>药品到期后一律弃用，过期药物不能“将就”服用。\u003C/li>\n        \u003C/ul>\n        \u003Cp>\n            储存环境的变化直接影响药效，务必定期检查家中药品状态。\n        \u003C/p>\n    \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n    \u003Cdiv class=\"bc-section-header\" style=\"background:linear-gradient(90deg,#faf4e9 0%,#edf6fa 100%);\">\n        \u003Ch2 class=\"bc-section-title\">09 漏服与过量处理：遇到问题怎么做？🤔\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bc-section-content\">\n        \u003Cp>\n            \u003Cstrong>漏服：\u003C/strong>按原计划继续下一次服药，不补服漏服剂量。对于注射药物，漏打一针应联系医生重新评估时间表。\n        \u003C/p>\n        \u003Cp>\n            \u003Cstrong>过量：\u003C/strong>出现乏力、心悸、腹泻等疑似中毒表现时应立即停止用药，尽快就医。绝不可自行做出增减剂量等操作。\n        \u003C/p>\n        \u003Cp>\n            正确做法：所有药品用量均应获得医生/药师正式确认，拒绝自行随意改动。\n        \u003C/p>\n    \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n    \u003Cdiv class=\"bc-section-header\" style=\"background:linear-gradient(90deg,#e6faf2 0%,#f9fafb 100%);\">\n        \u003Ch2 class=\"bc-section-title\">10 总结：安全用药关键点🌟\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bc-section-content\">\n        \u003Cp>\n            三期乳腺癌靶向药物的使用，虽能大幅提升治疗效果，但关键在于科学规范。牢记：\u003Cspan style=\"color:#3d7bb7;\">\u003Cstrong>严格遵循剂型和剂量要求、注意药物相互作用、及时发现与报告不良反应、按规定储存和妥善处理药品\u003C/strong>\u003C/span>，才能真正做到降低风险、优化效果。\n        \u003C/p>\n        \u003Cp>\n            \u003Cstrong>特别提醒：\u003C/strong>遇到任何用药疑问、药品异常或特殊情况，第一时间咨询专业医生或药师。科学的用药习惯，是安全治疗的根本保障。\n        \u003C/p>\n        \u003Cp>\n            以上就是靶向药物在三期乳腺癌治疗中需要关注的全部实用细节。把握这些核心点，日常用药更放心，也能为家人朋友提供更值得信赖的建议。\n        \u003C/p>\n    \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section-reference\">\n    \u003Ch3 class=\"bc-section-ref-title\">参考文献\u003C/h3>\n    \u003Cul class=\"bc-ref-list\">\n        \u003Cli>\n            Bang, Y. J., Van Cutsem, E., Feyereislova, A., et al. (2013). Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. \u003Cem>The Lancet\u003C/em>, 376(9742), 687-697.\n        \u003C/li>\n        \u003Cli>\n            Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., et al. (2005). Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 353(16), 1659-1672.\n        \u003C/li>\n        \u003Cli>\n            Geyer, C. E., Forster, J., Lindquist, D., et al. (2006). Lapatinib plus capecitabine for HER2-positive advanced breast cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 355(26), 2733-2743.\n        \u003C/li>\n    \u003C/ul>\n\u003C/div>\n\n\u003Cstyle>\n.bc-guide-title {\n    font-size: 36px;\n    font-weight: bold;\n    letter-spacing: 2px;\n    margin-top: 48px;\n    margin-bottom: 32px;\n    padding: 28px 16px;\n    color: #225380;\n    border-radius: 12px;\n    background: linear-gradient(90deg, #e6f3fb 0%, #f9fafb 100%);\n    text-align: center;\n    box-shadow: 0 6px 24px rgba(64,110,190,0.07);\n}\n.bc-section {\n    margin: 0 auto 40px auto;\n    background: #fff;\n    border-radius: 14px;\n    box-shadow: 0 3px 14px rgba(50,70,110,0.08);\n    max-width: 820px;\n}\n.bc-section-header {\n    padding: 28px 28px 16px 28px;\n    border-radius: 14px 14px 0 0;\n}\n.bc-section-title {\n    font-size: 28px;\n    margin: 0 0 2px 0;\n    letter-spacing: 1px;\n    font-weight: 700;\n    color: #3d7bb7;\n    display: flex;\n    align-items: center;\n}\n.bc-section-content {\n    padding: 24px 32px;\n    font-size: 20px;\n    color: #293a4a;\n    line-height: 1.88;\n    background: #fc;\n}\n.bc-section-content strong {\n    color: #225380;\n    font-weight: 600;\n}\n.bc-section-content ul {\n    padding-left: 28px;\n    margin-top: 12px;\n    margin-bottom: 12px;\n}\n.bc-section-content ul li {\n    font-size: 19px;\n    margin-bottom: 6px;\n    list-style-type: disc;\n}\n.bc-section-content em {\n    color: #757575;\n    font-size: 17px;\n}\n.bc-section-reference {\n    background: linear-gradient(90deg,#f8fbfa 0%,#eaf3fc 100%);\n    padding: 26px 32px;\n    margin: 0 auto 40px auto;\n    max-width: 820px;\n    border-radius: 9px;\n    box-shadow: 0 2px 12px rgba(60,90,160,0.09);\n}\n.bc-section-ref-title {\n    font-size: 23px;\n    color: #256295;\n    font-weight: 700;\n    margin-bottom: 13px;\n}\n.bc-ref-list {\n    font-size: 19px;\n    color: #2a3745;\n    padding-left: 18px;\n    margin-top: 0;\n}\n@media (max-width: 800px) {\n    .bc-guide-title { font-size: 28px; padding: 16px 6px; }\n    .bc-section { max-width: 98%; }\n    .bc-section-header { padding: 16px 10px 6px 10px; }\n    .bc-section-title { font-size: 21px; }\n    .bc-section-content { padding: 13px 8px; font-size: 16px; }\n    .bc-section-content ul li { font-size: 15px; }\n    .bc-section-reference { font-size: 15px; padding: 10px 8px;}\n    .bc-section-ref-title { font-size: 17px;}\n    .bc-ref-list { font-size: 15px;}\n}\n\u003C/style>","\u003Cdiv id=\"material_title\" class=\"bc-guide-title\">\n    三期乳腺癌靶向治疗：科学认识与实用指南\n\u003C/div>\n\n\u003Cdiv class=\"bc-sect",544,"2025-12-09 00:43:32","三期乳腺癌, 靶向药物, 曲妥珠单抗, 帕妥珠单抗, 用药指南, 不良反应, 用法用量, 药物相互作用, 安全用药, 老年患者用药, 医学科普","了解三期乳腺癌靶向治疗的重要知识，掌握靶向药物的成分、用法及不良反应，提升用药安全性与疗效，适合患者及家属阅读。","2025-12-15 14:18:18",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]